Issue 32 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

23

No.

32

August 15, 1997Aug 15, 1997

Free

DOWNLOAD THE PDF

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair

National Action Plan: Steering committee Votes No Confidence In HHS Official.

Professional Societies: Tobacco Industry Should Pay For Research, AACR Says

Federal Funding: IOM Report Praises DOD Breast Cancer Research Program

NCI RFA Available: Minority-Based CCOPS

Recent Issues

Volume 52 | Issue 25 - June 26, 2026

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026